Mackenzie Financial Corp lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 298,632 shares of the company’s stock after selling 27,372 shares during the quarter. Mackenzie Financial Corp’s holdings in Cardinal Health were worth $30,102,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Cornerstone Planning Group LLC bought a new stake in shares of Cardinal Health during the third quarter worth $26,000. BKM Wealth Management LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth $30,000. Retirement Group LLC grew its stake in shares of Cardinal Health by 1,539.3% in the fourth quarter. Retirement Group LLC now owns 459 shares of the company’s stock worth $35,000 after purchasing an additional 431 shares during the last quarter. ICA Group Wealth Management LLC bought a new stake in shares of Cardinal Health in the fourth quarter worth $41,000. Finally, Headlands Technologies LLC bought a new stake in shares of Cardinal Health in the third quarter worth $47,000. Institutional investors own 87.17% of the company’s stock.
Cardinal Health Stock Performance
NYSE CAH opened at $106.52 on Thursday. Cardinal Health, Inc. has a 52-week low of $77.56 and a 52-week high of $116.04. The company has a market capitalization of $25.91 billion, a P/E ratio of 41.94, a P/E/G ratio of 1.03 and a beta of 0.68. The company has a fifty day moving average of $109.46 and a 200-day moving average of $104.02.
Cardinal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were given a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.88%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio is currently 78.74%.
Analysts Set New Price Targets
Several analysts recently weighed in on CAH shares. Argus raised shares of Cardinal Health from a “hold” rating to a “buy” rating in a research note on Friday, February 9th. TheStreet lowered shares of Cardinal Health from a “b-” rating to a “c+” rating in a report on Wednesday, December 27th. UBS Group upped their price objective on shares of Cardinal Health from $122.00 to $125.00 and gave the company a “buy” rating in a report on Monday, February 5th. SVB Leerink started coverage on shares of Cardinal Health in a report on Monday, February 26th. They issued an “outperform” rating and a $125.00 target price on the stock. Finally, Barclays started coverage on shares of Cardinal Health in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price objective for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $103.07.
Read Our Latest Stock Analysis on CAH
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
- Five stocks we like better than Cardinal Health
- Insider Trading – What You Need to Know
- United Airlines Soars on Earnings Beat
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- J.B. Hunt Hits the Skids: Lower Prices to Come
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.